BAILARD, INC. - SANGAMO THERAPEUTICS INC ownership

SANGAMO THERAPEUTICS INC's ticker is SGMO and the CUSIP is 800677106. A total of 196 filers reported holding SANGAMO THERAPEUTICS INC in Q4 2019. The put-call ratio across all filers is 1.93 and the average weighting 0.0%.

Quarter-by-quarter ownership
BAILARD, INC. ownership history of SANGAMO THERAPEUTICS INC
ValueSharesWeighting
Q3 2021$1,802,000
-46.1%
200,000
-28.3%
0.06%
-46.1%
Q2 2021$3,341,000
-17.3%
279,100
-13.5%
0.12%
-23.3%
Q1 2021$4,042,000
-34.0%
322,600
-17.8%
0.15%
-46.2%
Q4 2020$6,122,000
+75.1%
392,300
+6.0%
0.28%
+54.1%
Q3 2020$3,497,000
-3.6%
370,100
-8.6%
0.18%
-10.8%
Q2 2020$3,629,000
+26.3%
405,000
-10.2%
0.20%
-1.0%
Q1 2020$2,873,000
+75.9%
451,000
+131.2%
0.20%
+122.8%
Q4 2019$1,633,000
-27.8%
195,100
-22.0%
0.09%
-32.8%
Q3 2019$2,263,000
+19.7%
250,100
+42.4%
0.14%
+18.1%
Q2 2019$1,891,000
+27.0%
175,600
+12.5%
0.12%
+26.1%
Q1 2019$1,489,000
+292.9%
156,100
+373.0%
0.09%
+253.8%
Q4 2018$379,000
-85.5%
33,000
-78.6%
0.03%
-83.0%
Q3 2018$2,619,000
+137.9%
154,500
+99.4%
0.15%
+131.8%
Q2 2018$1,101,000
+189.7%
77,500
+287.5%
0.07%
+175.0%
Q1 2018$380,00020,0000.02%
Other shareholders
SANGAMO THERAPEUTICS INC shareholders Q4 2019
NameSharesValueWeighting ↓
Golden State Equity Partners 154,360$897,0000.45%
Rhenman & Partners Asset Management AB 761,429$4,424,0000.44%
Lombard Odier Asset Management (Switzerland) SA 860,702$5,001,0000.39%
WASATCH ADVISORS LP 10,576,997$61,452,0000.30%
Rokos Capital Management LLP 977,663$5,861,0000.27%
KLK CAPITAL MANAGEMENT LLC 44,323$258,0000.26%
Long Focus Capital Management, LLC 340,000$1,975,0000.25%
Vanguard Capital Wealth Advisors 33,380$193,0000.14%
Fort Sheridan Advisors LLC 73,978$430,0000.13%
Delphia (USA) Inc. 20,983$122,0000.09%
View complete list of SANGAMO THERAPEUTICS INC shareholders